Fierce BioTech Summit 2023 | Questex | 15 October 2023 | The Westin Boston Seaport District, 425 Summer Street, Boston, MA 02210, USA

Join us at the summit where leaders and seasoned executives will come together to discuss the future of the industry this three-day event will cover the use of AI in drug development, unique deal making strategies, the latest innovations in oncology and much more. Uncover the latest research methodologies, cutting-edge technologies, and innovative approaches that accelerate the progression of promising scientific discoveries. From novel drug targets and therapeutic modalities to advanced preclinical models and trial design, sessions will cover a wide spectrum of topics that are pivotal to success in early-stage development. Join thought leaders, industry experts, investors, and executives to explore the intricacies of biotech strategy and the art of dealmaking. Take a deep dive into the changing landscape of deal structures, innovative licensing models, and successful case studies of strategic alliances.

Why you should attend:
• The Next Blockbuster Indications
• The Inflation Reduction Act (IRA): The Dawn of a New Era - What Will it Mean for Innovation?
• The Future of Oncology: Innovation and Advancements in the Biotech Industry
• Revolutionizing Drug Discovery and Development with AI: Maximizing Efficiency and Innovation in Biotech
• Success in the Middle of a Downturn: Strategies for Weathering the Biotech Storm and Building Trust in the Market
• Fierce 15 Panel – Where are they now?

2023 Speakers

Nadim Ahmed
President and Chief Executive Officer, Cullinan Oncology

Meg Alexander
Chief Strategy Officer, Ovid Therapeutics

Amanda Banks
Former CEO and advisor and board member , Blackfynn

Max Bayer
Staff Writer, Fierce Biotech

Michelle Benz
Conference Production Director Questex, Fierce Biotech

Janice Chen
Co-founder and Chief Technology Officer, Mammoth Biosciences

Lisa Deschamps
Chief Executive Office and Executive Board Member, AviadoBio

Leslie DeVos
President, Consulting Business Unit, Allucent

Ayla Ellison
Editor-in-Chief, Fierce Life Sciences and Healthcare

Agnete Fredrickson
Chief Scientific Officer and Co-Founder, nykode therapeutics

Laura Gault
Chief Medical Officer, Sage Therapeutics

Arjun Goyal
Co-founder and Managing Director, Vida Ventures

Alex Harding
SVP and Head of Business Development, CRISPR Therapeutics

Susan Hill
Chief Executive Officer, Mestag Therapeutics

Helen Ho
Chief Business Officer, Blueprint Medicines

Elizabeth Jeffords
President & CEO, Iolyx Therapeutics

Abbas Kazimi
Chief Business Officer, Nimbus Therapeutics

Junji Koizumi
Vice President, Head of Corporate Development and Strategic Operations, Astellas Pharma

Andrew Krivoshik
Chief Medical Officer, Frontier Medicines

Jeremy Levin
Chairman of the Board of Directors and Chief Executive Officer, Ovid Therapeutics, Inc.

Angus Liu
Senior Writer, Fierce Pharma

Angèle Maki
Senior Vice President, Business Development, ReCode Therapeutics

Mathai Mammen
CEO, Fog Pharma

Gabrielle Masson
Staff Writer, Fierce Biotech

Sharon Benzeno
Chief Commercial Officer, Immune Medicine, Adaptive Biotechnologies

Clare Murray
SVP, Head of Business Development & Strategy, ElevateBio

Shakti Narayan
Chief Executive Officer, Accent Therapeutics

Ajay Nirula
Sr. Vice President, Immunology Research, Lilly Research Labs, Eli Lilly

Sarah Noonberg
Chief Medical Officer, Metagenomi

Julia Owens
President & CEO, Ananke Therapeutics

Kelly Page
Senior Vice President, Global Head of Oncology Strategy and Program, Arvinas, Inc.

Joseph Panetta
President & CEO, Biocom California

Prakash Raman
President and Chief Executive Officer, Ribon Therapeutics

Thaminda Raminyake
Chief Business Officer, Affini-T Therapeutics

Alise Reicin
CEO, Tectonic Therapeutic

Joshua Schiffman
CEO and Co-Founder, Peel Therapeutics

Jason Silvers
CFO, Generate Biomedicines

Priya Singhal
EVP, Head of Development, Biogen

Devyn Smith
CEO, Arbor Biotechnologies

Alex Snyder
Chief Medical Officer, & Executive Vice President, Research, Generate Biomedicines

Jonathan Steckbeck
CEO & FOUNDER, Peptilogics

Uli Stilz
Vice President, Novo Nordisk Bio Innovation Hub

Clare Terlouw
Head, LifeArc Ventures

Nolan Townsend
Chief Executive Officer, LEXEO Therapeutics

David Weinstock
Vice President of Discovery Oncology, Merck

Rebecca Willumson
Senior Vice President & Publisher, Fierce Life Sciences

Alice Zhang
Chief Executive Officer and Co-founder, Verge Genomics

2023 Sponsors

PLATINUM SPONSORS:
• DNANexus
• Fujifilm Diosynth Biotechnologies

GOLD SPONSORS:
• Adaptive Biotechnologies
• Uncapped

SILVER SPONSORS:
• Allucent
• Curia

SPONSOR:
• SGS North America, Inc.

SUPPORTERS:
• Bia
• California Life Sciences Logo